medigraphic.com
ISSN 2448-8909 (Print)

2014, Number 4

<< Back Next >>

Med Crit 2014; 28 (4)

SOFA predictor as gravity scale in severe acute pancreatitis JPN measured by criteria

Muñoz-García A, Mendoza-Rodríguez M, Huerta-Valerio RM, López-González A, Sánchez-Domínguez R, Villa-Aranda R

Language: Spanish
References: 54
Page: 245-257
PDF size: 308.39 Kb.


ABSTRACT

Severe acute pancreatitis (SAP) is an inflammatory disease whose early stage is clinically an inflammatory reaction similar to systemic inflammatory response (SIRS), which evolves with dysfunction and/or multiorgan failure syndrome, which depends exclusively on management measures support in intensive care units (ICU). The severity can be assessed by the scale SOFA (Sequential Organ Dysfunction Assessment) to determine admission to ICU and set the prompt establishment of monitoring and management of severe acute pancreatitis. Timely ICU care of severe acute pancreatitis has been shown to decrease the occurrence of complications, mortality and treatment costs.
Objective: To determine the correlation between severity validity (established by criteria JPN guidelines for the management of acute pancreatitis: severity assessment of acute pancreatitis) and SOFA score as a predictor of severity.
Methods: Retrospective study.
Results: In patients with a predominance of male patients was found with a ratio of 2:1 (49 men versus 23 women) with a mean age of 38 ±14.34 and SD (minimum age 16, maximum 80), with an average stay of 9 days and a SD of ± 8.79 days (minimum stay 0 days, maximum 45 days). The SOFA respiratory component has the following results r = 0.1072 which shows a very low positive correlation. Regarding SOFA coagulation component is the present value of r = 0.2210 with a low positive correlation. The SOFA, in its hepatic component is the present value of r = 0.0941 and is interpreted as very low positive correlation. The SOFA cardiovascular component of the value obtained was 0.3916 and r could be interpreted as follows moderate positive correlation. Regarding SOFA, neurological component obtained value is r = 0.4024 indicating a moderate positive correlation. Regarding the SOFA, the value obtained renal component r = 0.4367 which implies a moderate positive correlation. Total SOFA regarding the present value is r = 0.6361 is interpreted as follows moderate positive correlation. SOFA delta relative to the value obtained r = 0.0933 with a very low positive correlation. Max. SOFA the value obtained is r = 0.5531 indicating a moderate positive correlation. Within the study the Max. delta SOFA value r = 0.3874 obtained with the following interpretation low positive correlation.
Conclusions: It can be inferred that the correlation between the SOFA total and score JPN is that could be used as a predictor severity scale, which is why the present study, but has several reviews and methodological considerations, clinical and bias to be considered before use as a predictor of isogravedad.


REFERENCES

  1. Doig CJ, Zygun DA, Fick GH, Laupland KB, Boiteau PJE, Shahpori R, et al. Study of clinical course of organ dysfunction in intensive care. Critical Care Medicine. 2004;32(2):384-390.

  2. Dugernier TL, Laterre PF, Wittebole X, Roeseler J, Latinne D, Reynaert MS, et al. Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. American journal of respiratory and Critical Care Medicine. 2003;168(2):148-57.

  3. Weiler H. Regulation of inflammation by the protein C system. Critical Care Medicine. 2010;38(2 Suppl):S18-S25.

  4. Beger HG, Rau B, Mayer J, Pralle U. Natural course of acute pancreatitis. World Journal of Surgery. 1997;21(2):130-135.

  5. Wang H, Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. The American Journal of Emergency Medicine. 2008;26(6):711-715.

  6. Nathens AB, Curtis JR, Beale RJ, Cook DJ, Moreno RP, Romand JA, et al. Management of the critically ill patient with severe acute pancreatitis. Critical Care Medicine. 2004;32(12):2524-2536.

  7. Dennis RJ, Pérez A, Rowan K, Londoño D, Metcalfe A, Gómez C, et al. Factors associated with hospital mortality in patients admitted to the intensive care unit in Colombia. Archivos de Bronconeumología. 2002;38(3):117-122.

  8. Cappell MS. Acute pancreatitis: etiology, clinical presentation, diagnosis, and therapy. The Medical Clinics of North America. 2008;92(4):889-923, IX-X.

  9. Hirota M, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, et al. JPN guidelines for the management of acute pancreatitis: severity assessment of acute pancreatitis. Journal of Hepato-Biliary-Pancreatic Surgery. 2006;13(1):33-41.

  10. Juneja D, Gopal PB, Ravula M. Scoring systems in acute pancreatitis: which one to use in intensive care units? Journal of Critical Care. 2010;25(2):358.e9-358.e15.

  11. Weber CK, Adler G. Acute pancreatitis. Curr Opin Gastroenterol. 2003;19(5):447-450.

  12. Windsor AC, Kanwar S, Li AG, Barnes E, Guthrie JA, Spark JI, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut. 1998;42(3):431-435.

  13. Muniraj T, Gajendran M, Thiruvengadam S, Raghuram K, Rao S, Devaraj P. Acute pancreatitis. Dis Mon. 2012;58(3):98-144.

  14. Miskovitz P. Scoring of multiple organ dysfunction in patients with severe acute pancreatitis. Critical Care Medicine. 2002;30(6):1390-1391.

  15. Mitchell RMS, Byrne MF, Baillie J. Pancreatitis. The Lancet. 2003;361(9367):1447-1455.

  16. Grant JP. Nutritional support in acute and chronic pancreatitis. The Surgical Clinics of North America. 2011;91(4):805-20, VIII.

  17. Bentrem DJ, Joehl RJ. Pancreas: healing response in critical illness. Critical Care Medicine. 2003;31(Suppl):S582-S589.

  18. Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut. 2000;47(4):546.

  19. Frossard JL, Hadengue A, Pastor CM. New serum markers for the detection of severe acute pancreatitis in humans. American Journal of Respiratory and Critical Care Medicine. 2001;164(1):162.

  20. Flint R, Windsor JA. Early physiological response to intensive care as a clinically relevant approach to predicting the outcome in severe acute pancreatitis. Archives of Surgery. 2004;139(4):438.

  21. Lundberg A, Granger D, Russell J. Quantitative measurement of P-and E-selectin adhesion molecules in acute pancreatitis: correlation with distant organ injury. Annals of Surgery. 2000;231(2):213-222.

  22. Matull WR, Pereira SP, O’Donohue JW. Biochemical markers of acute pancreatitis. Journal of Clinical Pathology. 2006;59(4):340-344.

  23. Kong L, Santiago N, Han TQ, Zhang SD. Clinical characteristics and prognostic factors of severe acute pancreatitis. World Journal of Gastroenterology. 2004;10(22):3336-3338.

  24. Hackert T, Hartwig W, Fritz S, Schneider L, Strobel O, Werner J. Ischemic acute pancreatitis: clinical features of 11 patients and review of the literature. American Journal of Surgery. 2009;197(4):450-454.

  25. Inagaki T, Hoshino M, Hayakawa T, Ohara H, Yamada T, Yamada H, et al. Interleukin-6 is a useful marker for early prediction of the severity of acute pancreatitis. Pancreas. 1997;14(1):1-8.

  26. Li H, Qian Z, Liu Z, Liu X, Han X, Kang H. Risk factors and outcome of acute renal failure in patients with severe acute pancreatitis. Journal of Critical Care. 2010;25(2):225-229.

  27. Marshall JC, Reinhart K. Biomarkers of sepsis. Critical Care Medicine. 2009;37(7):2290-2298.

  28. Poves-Prim I, Fabregat-Pous J, García-Borobia FJ, Jorba-Martí R, Figueras-Felip J, Jaurrieta-Mas E. Early onset of organ failure is the best predictor of mortality in acute pancreatitis. Rev Esp Enferm Dig. 2004;96(10):705-709, 709-713.

  29. Banks PA, Conwell DL, Toskes PP. The management of acute and chronic pancreatitis. Gastroenterology & Hepatology. 2010;6(2 Suppl 3):1-16.

  30. Rocha FG, Balakrishnan A, Ashley SW, Clancy TE. A historic perspective on the contributions of surgeons to the understanding of acute pancreatitis. American Journal of Surgery. 2008;196(3):442-449.

  31. Beck WC, Bhutani MS, Raju GS, Nealon WH. Surgical management of late sequelae in survivors of an episode of acute necrotizing pancreatitis. Journal of the American College of Surgeons. 2012;214(4):682-8;discussion 688-690.

  32. Privette TW, Carlisle MC, Palma JK. Emergencies of the liver, gallbladder, and pancreas. Emergency Medicine Clinics of North America. 2011;29(2):293-317, VIII-IX.

  33. Halonen KI, Pettilä V, Leppäniemi AK, Kemppainen EA, Puolakkainen PA, Haapiainen RK. Multiple organ dysfunctions associated with severe acute pancreatitis. Critical Care Medicine. 2002;30(6):1274-1279.

  34. Baue AE. Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets? Archives of Surgery. 1997;132(7):703-707.

  35. Beal AL. Multiple organ failure syndrome in the 1990s: systemic inflammatory response and organ dysfunction. JAMA. 1994;271(3):226.

  36. Buter A, Imrie CW, Carter CR, Evans S, McKay CJ. Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. The British Journal of Surgery. 2002;89(3):298-302.

  37. Isenmann R, Rau B, Beger HG. Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas. 2001;22(3):274-278.

  38. Sánchez-Lozada R, Camacho-Hernández MI, Vega-Chavaje RG, Garza-Flores JH, Campos-Castillo C, Gutiérrez-Vega R. Acute pancreatitis: five year experience at the Hospital General de Mexico. Gaceta Médica de México. 2005;141(2):123-127.

  39. Werner J, Feuerbach S, Uhl W, Büchler MW. Management of acute pancreatitis: from surgery to interventional intensive care. Gut. 2005;54(3):426-436.

  40. Le Mée J, Paye F, Sauvanet A, O’Toole D, Hammel P, Marty J, et al. Incidence and reversibility of organ failure in the course of sterile or infected necrotizing pancreatitis. Archives of Surgery. 2001;136(12):1386-1390.

  41. Williams M, Simms HH. Prognostic usefulness of scoring systems in critically ill patients with severe acute pancreatitis. Critical Care Medicine. 1999;27(5):901-907.

  42. Andersson R, Andersson B, Andersson E, Axelsson J, Eckerwall G, Tingstedt B. Acute pancreatitis-from cellular signalling to complicated clinical course. HPB. 2007;9(6):414-420.

  43. Yegneswaran B, Kostis JB, Pitchumoni CS. Cardiovascular manifestations of acute pancreatitis. Journal of Critical Care. 2011;26(2):225.e11-e18.

  44. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Critical Care Medicine. 1995;23(10):1638-1652.

  45. Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute physiology and chronic health evaluation (APACHE) IV: hospital mortality assessment for today’s critically ill patients. Critical Care Medicine. 2006;34(5):1297-1310.

  46. Ceriani R, Mazzoni M, Bortone F, Gandini S, Solinas C, Susini G, et al. Application of the sequential organ failure assessment score to cardiac surgical patients. Chest. 2003;123(4):1229-1239.

  47. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754-1758.

  48. Antonelli M, Moreno R, Vincent JL, Sprung CL, Mendoça A, Passariello M, et al. Application of SOFA score to trauma patients. Sequential organ failure assessment. Intensive Care Medicine. 1999;25(4):389-394.

  49. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on «sepsis-related problems» of the European Society of Intensive Care Medicine. Critical Care Medicine. 1998;26(11):1793-800.

  50. Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A, et al. The logistic organ dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU scoring group. JAMA. 1996;276(10):802-810.

  51. Arts DGT, de Keizer NF, Vroom MB, de Jonge E. Reliability and accuracy of sequential organ failure assessment (SOFA) scoring. Critical Care Medicine. 2005;33(9):1988-1993.

  52. Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA. 2004;291(23):2865-2868.

  53. Buda A. Life time of correlations and its applications. GlogoŽw: Andrzej Buda Wydawnictwo Niezależne; 2010.

  54. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754.




2020     |     www.medigraphic.com